Vaccinex Inc (VCNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,978 | -4,595 | -22,380 | -17,749 | -12,543 |
| Depreciation Amortization | 95 | 41 | 169 | 128 | 91 |
| Accounts receivable | N/A | N/A | 157 | 107 | 157 |
| Accounts payable and accrued liabilities | -795 | -472 | -2,108 | -2,220 | -1,448 |
| Other Working Capital | -725 | -584 | -3,210 | -3,380 | -2,247 |
| Other Operating Activity | 1,074 | 614 | 2,074 | 2,959 | 1,894 |
| Operating Cash Flow | $-10,329 | $-4,996 | $-25,298 | $-20,155 | $-14,096 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -52 | N/A | -32 | -32 | -22 |
| Investing Cash Flow | $-52 | $N/A | $-32 | $-32 | $-22 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -37 | -19 | -9 | 0 | N/A |
| Common Stock Issued | 13,229 | 13,229 | 32,848 | 32,848 | 32,848 |
| Other Financing Activity | 0 | 0 | -9,516 | -9,516 | -6,941 |
| Financing Cash Flow | $13,192 | $13,210 | $23,323 | $23,332 | $25,907 |
| Beginning Cash Position | 8,589 | 8,589 | 10,596 | 10,596 | 10,596 |
| End Cash Position | 11,400 | 16,803 | 8,589 | 13,741 | 22,385 |
| Net Cash Flow | $2,811 | $8,214 | $-2,007 | $3,145 | $11,789 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,329 | -4,996 | -25,298 | -20,155 | -14,096 |
| Capital Expenditure | -52 | N/A | -32 | -32 | -22 |
| Free Cash Flow | -10,381 | -4,996 | -25,330 | -20,187 | -14,118 |